|
Mutation Information
|
Mutation Site
|
M204I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Genotype/Subtype
|
A2 |
|
Viral Reference
|
X70185.1
|
|
Relevant Drug
|
lamivudine (LAM);adefovir (ADV);entecavir (ETV) |
Literature Information
|
PubMed PMID
|
22453135
|
|
Disease
|
Chronic hepatitis B
|
|
Published Year
|
2012 |
|
Journal
|
Antiviral research |
|
Title
|
Long-term monitoring drug resistance by ultra-deep pyrosequencing in a chronic hepatitis B virus (HBV)-infected patient exposed to several unsuccessful therapy schemes. |
|
Author
|
Sede M,Ojeda D,Cassino L,Westergaard G,Vazquez M,Benetti S,Fay F,Tanno H,Quarleri J |
|
Evidence
|
Under sequential HBV monotherapies including lamivudine, adefovir and entecavir, a high frequency of rtM204I mutation was detected initially as unique and then coexisting with rtM204V.
|
|
|